OVID
Ovid Therapeutics Inc
2.50$
-2.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -146.6% | – | – | – | |
| – | +408.8% | +379.8% | +42.1% | +76.5% | +79.9% | +20.3% | -22.7% | +482.8% | +15.6% | -61.6% | -55.5% | |
| – | +4,304.5% | +149.9% | +75.7% | +10.4% | -26.3% | +44.6% | -32.8% | +29.7% | +11.1% | -13.9% | -23.4% | |
| – | +17,581.1% | -37.8% | +785.9% | -78.1% | -26.4% | +40.7% | -31.0% | +29.7% | – | – | – | |
| – | +3,956.0% | -49.6% | +9.0% | -179.0% | – | +453.9% | -177.1% | – | – | -106.3% | – | |
| – | +3,059.4% | +235.5% | -74.9% | +642.9% | -30.7% | +60.1% | -51.5% | +649.1% | -90.3% | -48.3% | -100.0% | |
| – | +821.1% | +235.5% | -74.9% | +11,218.8% | +460.1% | – | -105.3% | +4,725.0% | -97.1% | – | -191.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +278,742.5% | -1.2% | 0.0% | -99.6% | +22,355.0% | -26.7% | -98.1% | -80.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +949.6% | -100.0% | – | -99.6% | +30,143.7% | -45.6% | -98.1% | -80.0% | +16,802.2% | -98.0% | +11,991.2% | |
| – | +907.3% | -127.7% | – | -243.9% | – | +457.3% | +290.5% | -221.4% | – | – | – | |
| – | – | – | – | – | – | – | – | -147.8% | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.